SSA
CPIX icon

Schonfeld Strategic Advisors’s Cumberland Pharmaceuticals CPIX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,900
Closed -$75.7K – 2110
2025
Q1 		$75.7K Buy
+17,900
New +$74.2K ﹤0.01% 2045
2024
Q4 		– Sell
-10,000
Closed -$12.8K – 2064
2024
Q3 		$12.8K Buy
+10,000
New +$13.8K ﹤0.01% 1923
2022
Q1 		– Sell
-20,200
Closed -$94K – 2635
2021
Q4 		$94K Buy
+20,200
New +$68.9K ﹤0.01% 1902

Other funds holding CPIX

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Schonfeld Strategic Advisors's CPIX Position: Q2 2025 in Review

Schonfeld Strategic Advisors sold out of Cumberland Pharmaceuticals (CPIX) in Q2 2025, closing a stake of 17,900 shares — an estimated $75.7K sold.

Schonfeld Strategic Advisors first reported a position in CPIX in Q4 2021 and held it in 3 quarters. The position peaked at $94K in Q4 2021. 31 funds tracked by Wall St. Rank hold CPIX as of Q2 2025.

  • Schonfeld Strategic Advisors reported no remaining Cumberland Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 17,900 Cumberland Pharmaceuticals shares in Q2 2025, an estimated $75.7K.
  • Schonfeld Strategic Advisors first reported a position in Cumberland Pharmaceuticals in Q4 2021 and held it in 3 quarters.
  • Schonfeld Strategic Advisors's Cumberland Pharmaceuticals position peaked at $94K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.